Literature DB >> 17161778

TASC II document on the management of peripheral arterial disease.

D J Adam, A W Bradbury.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17161778     DOI： 10.1016/j.ejvs.2006.11.008

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN： 1078-5884            Impact factor:   7.069


× No keyword cloud information.
  13 in total

Review 1.  Clinical efficacy and safety of cilostazol: a critical review of the literature.

Authors:  Kelly C Rogers; Carrie S Oliphant; Shannon W Finks
Journal:  Drugs       Date:  2015-03       Impact factor: 9.546

2.  Percutaneous intentional intra-luminal-assisted recanalization (PILAR technique) of challenging chronic total occlusions using a high-frequency vibration device.

Authors:  Stephanie Volpi; Amine Chouiter; Francois Saucy; Steven Hajdu; Anne-Marie Jouannic; Salah D Qanadli
Journal:  Eur Radiol       Date:  2018-05-22       Impact factor: 5.315

3.  Excimer laser ablation combined with drug-coated balloon versus drug-coated balloon in the treatment of de novo atherosclerotic lesions in lower extremities (ELABORATE): study protocol for a real-world clinical trial.

Authors:  Xiaolang Jiang; Longhua Fan; Bin Chen; Junhao Jiang; Jianjun Liu; Guanyu Qiao; Shuai Ju; Yun Shi; Tao Ma; Changpo Lin; Gang Fang; Daqiao Guo; Xin Xu; Zhihui Dong; Weiguo Fu
Journal:  BMC Cardiovasc Disord       Date:  2022-07-16       Impact factor: 2.174

4.  Arterial compliance across the spectrum of ankle-brachial index: the Multiethnic Study of Atherosclerosis.

Authors:  Scott M Lilly; David R Jacobs; Richard Kronmal; David A Bluemke; Michael Criqui; Joao Lima; Matthew Allison; Daniel Duprez; Patrick Segers; Julio A Chirinos
Journal:  Atherosclerosis       Date:  2014-02-12       Impact factor: 5.162

5.  Feasibility and Mid-Term Outcomes of Drug-Coated Balloon Angioplasty Between Intermittent Claudication and Critical Limb Ischemia in Patients with Femoropopliteal Disease.

Authors:  Chien-An Hsieh; Shing-Hsien Chou; I-Chih Chen; Shih-Jung Jang; Hsin-Hua Chou; Yu-Lin Ko; Hsuan-Li Huang
Journal:  Acta Cardiol Sin       Date:  2019-05       Impact factor: 2.672

6.  Hydrogen Sulfide Levels and Nuclear Factor-Erythroid 2-Related Factor 2 (NRF2) Activity Are Attenuated in the Setting of Critical Limb Ischemia (CLI).

Authors:  Kazi N Islam; David J Polhemus; Erminia Donnarumma; Luke P Brewster; David J Lefer
Journal:  J Am Heart Assoc       Date:  2015-05-14       Impact factor: 5.501

7.  Effective endovascular treatment of calcified femoropopliteal disease with directional atherectomy and distal embolic protection: final results of the DEFINITIVE Ca⁺⁺ trial.

Authors:  David Roberts; Khusrow Niazi; William Miller; Prakash Krishnan; Roger Gammon; Theodore Schreiber; Nicolas W Shammas; Daniel Clair
Journal:  Catheter Cardiovasc Interv       Date:  2014-02-05       Impact factor: 2.692

Review 8.  The Evolving Treatment of Peripheral Arterial Disease through Guideline-Directed Recommendations.

Authors:  Ramez Morcos; Boshra Louka; Andrew Tseng; Sanjay Misra; Robert McBane; Heidi Esser; Fadi Shamoun
Journal:  J Clin Med       Date:  2018-01-09       Impact factor: 4.241

9.  Assessment of effectiveness of endovascular treatment of common and external iliac artery stenosis/occlusion using self-expanding Jaguar SM stents.

Authors:  Kazimierz Kordecki; Adam Lukasiewicz; Mirosław Nowicki; Andrzej Lewszuk; Radosław Kowalewski; Bogusław Panek; Michał Zawadzki; Paweł Michalak; Marek Gacko; Urszula Lebkowska
Journal:  Pol J Radiol       Date:  2012-10

10.  IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial.

Authors:  Thomas Zeller; Iris Baumgartner; Dierk Scheinert; Marianne Brodmann; Marc Bosiers; Antonio Micari; Patrick Peeters; Frank Vermassen; Mario Landini
Journal:  Trials       Date:  2014-02-19       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.